Otolaryngologic manifestations in HIV disease - clinical aspects and treatment

Brazilian Journal of Otorhinolaryngology

Volumn 77, Issue 3, 2011, Pages 391-400

  Sanjar, Fernanda Alves ^a   Queiroz, Barbara Elvina Ulisses Parente ^a   Miziara, Ivan Dieb ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Acquiredimmunodeficiencysyndrome; Aids relatedopportunisticinfections; Anti hiv agents; Hiv; Oral manifestations

Indexed keywords

EID: 79960367626     PISSN: 18088694     EISSN: 18088686     Source Type: Journal    
DOI: 10.1590/S1808-86942011000300020     Document Type: Article

References (64)

1. Prasad HK, Bhojwani KM, Shenoy V, Prasad SC. HIV manifestations in otolaryngology. Am J Otolaryngol. 2006;27(3):179-185.
2. Ranganathan K, Hemalatha R. Oral lesions in HIV infection in developing countries: an overview. Adv Dent Res. 2006;19(1):63-68.
3. Miziara ID, Weber R. Oral candidosis and oral hairy leukoplakia a predictors of HAART failure in Brazilian HIV-infected patients. Oral Dis.2006;12:402-407.
4. Pienaar ED, Young T, Holmes H. Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children. (Cochrane Review). In: The Cochrane Library, Issue 3, 2007. Oxford: Update Software.
5. Reznik DA. Oral manifestations of HIV disease. Top HIV Med. 2005-2006;13(5):143-148.
6. Hodgson TA, Greenspan D, Greenspan JS. Oral lesions of HIV disease and HAART in industrialized countries. Adv Dent Res. 2006;19:57-62.
7. Ramirez-Amador V, Ponce-de-Leon S, Anaya-Saavedra G, Ramirez BC, Sierra-Madero J. Oral Lesions as Clinical Markers of Highly Active Antiretroviral Therapy Failure: A Nested Case-Control Study in Mexico City. Clin Infect Dis. 2007;45(7)925-932.
8. Reichart PA. Oral manifestations in HIV infection: fungal and bacterial infections, Kaposi's sarcoma. Med Microbiol Immunol. 2003;192:165-169.
9. Lilly EA, Cameron JE, Shetty KV, Leigh JE, Hager S, McNulty KM, et al. Lack of evidence for local immune activity in oral hairy leukoplakia and oral wart lesions. Oral Microbiol Immunol. 2005;20(3):154-162.
10. Webster-Cyriaque J, Duus K, Cooper C, Duncan M. Oral EBV and KSHV infection in HIV. Adv Dent Res. 2006;19(1):91-95.
11. Baccaglini L, Atkinson JC, Patton LL, Glick M, Ficarra G, Peterson DE. Management of oral lesions in HIV-positive pacients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;103(suppl 01):S50.e1-S50e23.
12. Kerr AR, Ship JA. Management strategies for HIV-associated aphthous stomatitis. Am J Clin Dermatol.2003;4(10):669-680.
13. Miziara ID, Araujo Filho BC, Weber R. AIDS e estomatite aftóide recidivante. Braz J Otorhinolaringol. 2005;71(4):517-520.
14. Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, et al. Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. New Engl J Med. 1997;336(21):1487-1493.
15. Jacobson JM, Greenspan JS, Spritzler J, Fox L, Fahey JL, Jackson JB, et al. Thalidomide in low intermittent doses does not prevent recurrence of human immunodeficiency virus associated aphthous ulcers. J Infect Dis. 2001;183(2):343-346.
16. Kalpidis CDR, Lysitsa SN, Lombardi T, Kolokotronis AE, Anto-niades DZ, Samson J. Gingival involvement in a case series of patients with Acquired Immunodeficiency Syndrome-related Kaposi sarcoma. J Periodontol. 2006;77(3):523-532.
17. Baumgarth N, Szubin R, Dolganov GM, Watnik MR, Greenspan D, Da Costa M, et al. Highly tissue substructure-specific effects of human papilloma virus in mucosa of HIV-infected patients revealed by laser-dissection microscopy assisted gene expression profiling. Am J Pathol. 2004;165(3):707-718.
18. Robinson PG, Sheiham A, Challacombe SJ, Zakrzewska JM. Periodontal health and HIV infection. Oral Dis. 1997;3(suppl 1):S149-S152.
19. Miziara ID. Tuberculosis affecting the oral cavity in Brazilian HIV-infected patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;100(2):179-182.
20. Ministério da Saúde - Secretaria de Vigilância em Saúde - Pro-grama Nacional de DST e AIDS. Recomendações para terapia anti-retroviral em adultos e adolescentes infectados pelo HIV 2007/2008. Documento preliminar. Brasília - DF 2007.
21. Carbone A, Gloghini A. AIDS-related lymphomas: from patho-genesis to pathology. Br J Haematol. 2005;130(5):662-670.
22. Tami T, Wawrose SF. Disease of the nose and paranasal sinuses in the human immunodeficiency virus-infected population. Oto-laryngol Clin North Am. 1992;25:1199-1210.
23. Gurney T, Lee K, Murr A. Contemporary issues in rhinosinusitis and HIV infection. Curr Opin Otolaryngol Head Neck Surg. 2003;11(1)45-48.
24. Gurney T, Murr A. Otolaryngologic manifestations of human immunodeficiency virus infection. Otolaryngol Clin N Am. 2003;36:607-624.
25. Miziara ID, Araujo Filho BC, La Cortina RC, Romano FR, Lima AS. Chronic rhinosinusitis in HIV-infected patients: radiological and clinical evaluation. Rev Bras Otorrinolaringol. 2005; 71(5):604-608.
26. Randhawa IS, junaid I, Klaustermeyer WB. Allergen immuno-therapy in a patient with human immunodeficiency virus: effect on T-cell activation and viral replication. Ann Allergy asthma Immunol. 2007;98(5):495-497.
27. Srirompotong S, Ymtae K, Srirompotong S. Tuberculosis in the upper aerodigestive tract and human immunodeficiency virus coinfections. J Otolaryngol. 2003;32(4):230-233.
28. Mandel L, Surattanont F. Regression of HIV parotid swellings after antiviral therapy: case reports with computed tomographic scan evidence. Oral Surg Oral Med Oral Pathol Oral Raiol Endod. 2002;94(4):454-459.
29. Favia G, Capodiferro S, Scivetti M, Lacaita MG, Filosa A, Lo Muzio L. Multiple parotid lymphoepitelial cysts in patients with HIV-infection: report of two cases. Oral Dis. 2004;10(3):151-154.
30. Steele NP, Sampogna D, Sessions RB. Kaposi ́s Sarcoma of an Intraparotid Lymph Node Leading to a Diagnosis of HIV. Laryngoscope. 2005;115:861-863.
31. Riviera H, Nikitakis NG, Castillo S, Siavash H, Papadimitriou JC, Sauk JJ. Histopathological analysis and demonstration of EBV and HIV p-24 antigen but not CMV expression in labial minor salivary glands of HIV patients affected by diffuse infiltrative lymphocytosis syndrome. J Oral Pathol Med. 2003;32(7):431-437.
32. Tripathi AK, Gupta N, Ahmad R, Bandhari HS, Kalra P. HIV disease presenting as parotid lymphoepitelial cysts: a presumptive diagnosis of diffuse infiltrative lymphocytic syndrome. J Assoc Physicians India. 2004;52:921-923.
33. Franco-Paredes C, Rebolledo P, Folch E, Hernandez I, del Rio C. Diagnosis of diffuse CD 8+ lymphocytosis syndrome in HIV-infected patients. AIDS Read. 2002; 12(9): 408-413.
34. Feller L, White JP, Bouckaert M, Muthupei MN. Diffuse infiltrative CD 8+ lymphocytosis syndrome: review of the literature and repor of a case. SADJ. 2007;62(7):214-217.
35. Basu D, Williams FM, Ahn CW, Reveille JD. Changing spectrum of the diffuse infiltrative lymphocytosis syndrome. Arthritis Rheum. 2006;55(3):466-472.
36. Rinaldo A, Brandwein M, Devaney K, Ferlito A. AIDS-related Otological Lesions. Acta Otolaryngol. 2003;123:672-674.
37. Chandrasekhar SS, Conelly PE, Brahmbhatt SS, Shah CS, Kloser PC, Baredes S. Otologic and audilogic evaluation of human immunodeficiency virus-infected patients. Am J Otolaryngol. 2000;21(1):1-9.
38. Morris MS, Prasad S. Otologic disease in the acquired immunodeficiency syndrome. Ear Nose Throat J. 1990;69(7):451-453.
39. Madriz JJ, Herrera G. Human Immunodeficiency Virus and Acquired Immune Deficiency Syndrome AIDS-related Hearing Disorders. J Am Acad Audiol.1995;6:358-3564.
40. Hern JD, Almeyda J, Thomas DM, Main J, Patel KS. Malignant otitis extern in HIV and AIDS. J Laryngol Otol. 1996;110:770-775.
41. Gangadhar SS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003,11:316-23.
42. Rubin Grandis J, Branstetter BF. The changing face of malignant (necrotizing) external otitis: clinical, radiological, and anatomic correlations. Lancet Infect Dis. 2004;4(1):34-39.
43. Ress B, Luntz M, Telischi F, Balkany TJ, Whiteman MLH. Ne-crotizing External Otitis in Patients with AIDS. Laryngoscope. 1997;107(4):456-460.
44. Kielofner M, Atmar RL, Hamill RJ, Musher DM. Life-threatening Paseudomonas aeruginosa infectious in patients with human immunodeficiency virus infection. Clin Infect Dis. 1992;14(2): 403-11.
45. Trauss M, Fine E. Aspergillus Otomastoiditis in Acquired Immunodeficiency Syndrome. Am J Otol. 1991;12(1):40-53.
46. Chandrasekhar SS, Siverls V, Chandrasekhar HK. Histopatologica And Ultrastructural Changes In The Temporal Bones Of HIV-Infected human Adults. Am J Otol. 1992;13(3):207-214.
47. Michaels L, Soucek S, Liang J. The Ear In The Acquired Immunodeficiency Syndrome: I. temporal Bone Histopatologic Study. Am J Otol. 1994;15(4):515-522.
48. Newton JP. The causes of hearing loss in HIV infection. Community Ear and Hearing Health:2006;3:1-16 Issue n. 3.
49. Marchisio P, Principi N, Sorella S, Sala E, Tornaghi R. Etiology of acute otitis media in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1996;15(1):58-61.
50. Miziara ID, Weber R, Cunha Filho BA, Pinheiro Neto CD. Otitis media in Brazilian human immunodeficiency virus infected children undergoing antiretroviral therapy. J Laryngol Otol 2007;121:1048-1054.
51. Barnett ED, Kline JO, Pelton SI, luginbuhl LM. Otitis media in children born to human immunodeficiency virus-infected mothers. Pediatr Infect Dis J 1992;11:360-364.
52. Godofsky EW, Zinreich J, Armstrong M, Leslie JM, Weickel CS. Sinusitis in HIV-infected patients: a clinical and radiographic review. Am J Med. 1992;93:163-170.
53. Zucotti G, Dauria E, Torcoletti M, Lodi F, Bernardo L, Riva E. Clinical and pro-host effects of cefaclor in prophylaxis of recurrent otitis media in HIV-infected children. J Int Med Res. 2001;29(4):349-354.
54. Chen AY, Ohlms L, Stewart M, Kline M. Otolaryngologic Disease Progression in Children with Human Immunodeficiency Virus Infection. Arch Otolarynol Head Neck Surg. 1996;122(12):1360-1363.
55. Shapiro LN, Novelli V. Otitis media in children with vertically-acquired HIV infection: the Great Ormond Street Hospital experience. Int J Ped Otorhinolaryngol. 1998;45:69-75.
56. Nachman S, Kim S, King J, Abrams E, Margolis D, Petru A, et al. Safety and Immunogenicity of a Heptavalent pneumococcal Conjugate Vaccine in Infants With Human Immunodeficiency Virus Type 1 infection. Pediatrics. 2003;112;66-73.
57. Kohan D, Giacchi RJ. Otologic surgery in patients with HIV-1 and AIDS. Otolaryngol Head Neck Surg. 1999;121(4):355-360.
58. Thorp MA. Needle myringotomy: a useful technique with the increased prevalence of the human immunodeficiency virus. J Laryngol Otol. 1998;112:865-866.
59. Bernaldez P, Morales G, Hernandez C. Chronic Suppurative Oitis Media in HIV-Infected Children. Otolaryngol Head Neck Surg. 2005;133(2):243-244.
60. Praveen CV, Terry RM, Elmahallawy M, Horsfield C. Pneumocystis carinii infection in bilateral aural polyps in a human immunodeficiency virus-positive patient. J Laryngol Otol. 2002;116:288-290.
61. Manger DJ, Berg RG. Pneumocystis carinii infection of the middle ear and external auditory canal. Report of a case and review of the literature. ORL J Otorhinolaryngol Relat Spec. 2003;65(1):49-51.
62. CDC 1993 revised classification system for HIV infection and expanded surveillence case definition for AIDS among adolescents and adults. MMWR 1992/41 (RR-17).
63. Sasaki M, Leite P, Leite A, Almeida S. Bilateral peripheral facial palsy secondary to lymphoma in a patient with HIV/AIDS. Braz J Infec Dis. 2002;6(1):50-54.
64. Kim MS, Yoon HJ, Kim HJ, Nam JS, Choi SH, Kim JM, Song YG. Bilateral peripheral facial palsy in a patient with Human Immunodeficiency Virus (HIV) infection. Med J. 2006;47(5):745-747.